Our Company
What We Do
Mission Statement
Leadership Team
Our Clinical Trials
MultiVir Clinical Trials
Patients and Families
Medical Professionals
Technologies
Tumor Suppressor Immune Gene Therapy
Dendritic Cell Therapeutic Vaccines
Patients and Families
Welcome Patients and Families
MultiVir Clinical Trials
Medical Professionals
Medical Professionals
Investors and Media
Investors and Media
Search
Uncategorized
Multivir Reports Novel Triplet Cancer Immunotherapy
by Nick Puro
MultiVir Announces First Patient Treated in Human Clinical Trail of Tumor Suppressor p53 Immune Gene Therapy In Combination with immune Checkpoint Inhibitors
by Nick Puro
Moffitt Cancer Center Announces Licensing Agreement to Develop New Therapeutic Cancer Vaccine July 10, 2018
by Nick Puro
MultiVir Announces Funding from the National Institutes of Health to Develop Novel Cancer Gene Therapy
by Nick Puro
MultiVir Reports Gene Therapy Enhancement of Cancer Immunotherapy
MultiVir Reports Gene Therapy Enhancement of Cancer Immunotherapy ...
by Nick Puro